Time-domain diffuse optical imaging technique for monitoring rheumatoid arthritis disease activity: theoretical development and in silico validation
View abstract on PubMed
Summary
This summary is machine-generated.New time-domain diffuse optical imaging (TD-DOI) features show higher sensitivity to rheumatoid arthritis (RA) disease activity. This technique may enable earlier detection of RA treatment failure, improving patient outcomes.
Area Of Science
- Biomedical Optics
- Medical Imaging
- Rheumatology
Background
- Effective early treatment within 3-5 months of onset significantly improves rheumatoid arthritis (RA) prognosis.
- Treatment failure occurs in one-third of RA patients and takes 3-6 months to detect with current methods.
- Early detection of treatment failure is crucial for timely intervention and improved patient prognosis.
Purpose Of The Study
- To develop a method for extracting quantitative features from time-domain diffuse optical imaging (TD-DOI) data.
- To demonstrate the sensitivity of these features to rheumatoid arthritis (RA) disease activity.
- To explore TD-DOI's potential for earlier detection of RA treatment failure.
Main Methods
- Creation of 80 virtual phantoms simulating RA-induced joint alterations based on MRI data.
- Generation of TD-DOI images using Monte Carlo simulations with added Poisson noise.
- Extraction and correlation of spatiotemporal features (e.g., Fourier components) with disease index, correcting for instrument response function (IRF).
Main Results
- Spatiotemporal Fourier components of TD-DOI images strongly correlated with disease index, even with noise and IRF effects.
- Lower temporal frequency components (≤0.4 GHz) showed greater sensitivity to minor disease activity changes than previous spatial features.
- The developed method demonstrated potential for quantitative assessment of RA disease activity.
Conclusions
- Spatiotemporal components derived from TD-DOI show enhanced sensitivity to RA disease activity compared to existing DOI features.
- TD-DOI holds promise for earlier identification of RA treatment failure.
- This advancement could significantly reduce diagnosis time and improve overall patient prognosis in RA management.

